Role of downregulated miR-133a-3p expression in bladder cancer: A bioinformatics study

OncoTargets and TherapyGao L, et al. | August 07, 2017

Advertisement

Study authors sought to validate the expression of miR–133a–3p in bladder cancer (BC) and provide insights into the molecular mechanism underlying it. Possessing great diagnostic potential with its downregulation in BC, miR–133a–3p appeared as a novel biomarker for BC.

Read the full article on OncoTargets and Therapy

Advertisement